| 1 | Hepatic cell mobilization for protection against ischemic myocardial injury. (Liu SQ, Troy JB, Luan CH, Guillory RJ) Sci Rep 2021 Aug 04;11(1):15830 5 Citations |
| 1 | Evaluating the effects of carbon monoxide releasing molecule-2 against myocardial ischemia-reperfusion injury in ovariectomized female rats. (Kumar A, Boovarahan SR, Prem PN, Ramanathan M, Chellappan DR, Kurian GA) Naunyn Schmiedebergs Arch Pharmacol 2021 Oct;394(10):2103-2115 7 Citations |
| 1 | Venovenous Versus Venoarterial Extracorporeal Membranous Oxygenation in Inotrope Dependent Pediatric Patients With Respiratory Failure. (Jaber B, Bembea MM, Loftis LL, Spinella PC, Zhang L, Simpson PM, Hanson SJ,
the Pediatric ECMO (PediECMO) Subgroup of the Pediatric Acute Lung Injury
and
Sepsis Investigators (PALISI) Network
and
the Extracorporeal Life Support Organization (ELSO)) ASAIO J 2021 Apr 01;67(4):457-462 12 Citations |
| 2 | Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy. (Gartz M, Lin CW, Sussman MA, Lawlor MW, Strande JL) Dis Model Mech 2020 Nov 13;13(11) 26 Citations |
| 1 | Biphasic effect of metformin on human cardiac energetics. (Emelyanova L, Bai X, Yan Y, Bosnjak ZJ, Kress D, Warner C, Kroboth S, Rudic T, Kaushik S, Stoeckl E, Ross GR, Rizvi F, Tajik AJ, Jahangir A) Transl Res 2021 Mar;229:5-23 33 Citations |
| 2 | BCR-ABL tyrosine kinase inhibitors promote pathological changes in dilator phenotype in the human microvasculature. (Durand MJ, Hader SN, Derayunan A, Zinkevich N, McIntosh JJ, Beyer AM) Microcirculation 2020 Oct;27(7):e12625 8 Citations |
| 1 | Epithelial and Endothelial Adhesion of Immune Cells Is Enhanced by Cardiotonic Steroid Signaling Through Na+/K+-ATPase-α-1. (Khalaf FK, Tassavvor I, Mohamed A, Chen Y, Malhotra D, Xie Z, Tian J, Haller ST, Westfall K, Tang WHW, Kennedy DJ) J Am Heart Assoc 2020 Feb 04;9(3):e013933 13 Citations |
| 3 | Ability of CP-532,903 to protect mouse hearts from ischemia/reperfusion injury is dependent on expression of A3 adenosine receptors in cardiomyoyctes. (Wan TC, Tampo A, Kwok WM, Auchampach JA) Biochem Pharmacol 2019 May;163:21-31 13 Citations |
| 1 | A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state. (Melchior JT, Walker RG, Cooke AL, Morris J, Castleberry M, Thompson TB, Jones MK, Song HD, Rye KA, Oda MN, Sorci-Thomas MG, Thomas MJ, Heinecke JW, Mei X, Atkinson D, Segrest JP, Lund-Katz S, Phillips MC, Davidson WS) Nat Struct Mol Biol 2017 Dec;24(12):1093-1099 61 Citations |
| 1 | Sodium Thiosulfate Preconditioning Ameliorates Ischemia/Reperfusion Injury in Rat Hearts Via Reduction of Oxidative Stress and Apoptosis. (Ravindran S, Boovarahan SR, Shanmugam K, Vedarathinam RC, Kurian GA) Cardiovasc Drugs Ther 2017 Dec;31(5-6):511-524 53 Citations |
| 2 | Endogenous and Agonist-induced Opening of Mitochondrial Big Versus Small Ca2+-sensitive K+ Channels on Cardiac Cell and Mitochondrial Protection. (Stowe DF, Yang M, Heisner JS, Camara AKS) J Cardiovasc Pharmacol 2017 Nov;70(5):314-328 20 Citations |
| 2 | Cardiotonic Steroids Stimulate Macrophage Inflammatory Responses Through a Pathway Involving CD36, TLR4, and Na/K-ATPase. (Chen Y, Huang W, Yang M, Xin G, Cui W, Xie Z, Silverstein RL) Arterioscler Thromb Vasc Biol 2017 Aug;37(8):1462-1469 32 Citations |
| 6 | Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes. (Schloemer NJ, Brickler M, Hoffmann R, Pan A, Simpson P, McFadden V, Block J, Tower RL 2nd, Burke MJ) J Pediatr Hematol Oncol 2017 Jul;39(5):e254-e258 18 Citations |
| 1 | Eicosapentaenoic acid ameliorates palmitate-induced lipotoxicity via the AMP kinase/dynamin-related protein-1 signaling pathway in differentiated H9c2 myocytes. (Sakamoto A, Saotome M, Hasan P, Satoh T, Ohtani H, Urushida T, Katoh H, Satoh H, Hayashi H) Exp Cell Res 2017 Feb 01;351(1):109-120 24 Citations |
| 3 | Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice. (Baumgardt SL, Paterson M, Leucker TM, Fang J, Zhang DX, Bosnjak ZJ, Warltier DC, Kersten JR, Ge ZD) Circ Heart Fail 2016 Jan;9(1):e002424 56 Citations |
| 1 | Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404. (Asselin BL, Devidas M, Chen L, Franco VI, Pullen J, Borowitz MJ, Hutchison RE, Ravindranath Y, Armenian SH, Camitta BM, Lipshultz SE) J Clin Oncol 2016 Mar 10;34(8):854-62 168 Citations |
| 1 | A Scientist-Skeptic-Agnostic's View of the Church of Anesthetic Cardioprotection. (Pagel PS) J Cardiothorac Vasc Anesth 2015 Dec;29(6):e77-8 |
| 1 | Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. (Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE) Pediatr Blood Cancer 2016 Jan;63(1):54-61 84 Citations |
| 1 | Anesthetic "Conditioning:" A Continuing Question of Clinical Relevance. (Pagel PS) J Cardiothorac Vasc Anesth 2015 Dec;29(6):e75-6 2 Citations |
| 3 | MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt/Nitric Oxide Synthase/Mitochondrial Permeability Transition Pore Pathway. (Qiao S, Olson JM, Paterson M, Yan Y, Zaja I, Liu Y, Riess ML, Kersten JR, Liang M, Warltier DC, Bosnjak ZJ, Ge ZD) Anesthesiology 2015 Oct;123(4):786-798 70 Citations |
| 1 | Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis. (Lim JY, Deo SV, Rababa'h A, Altarabsheh SE, Cho YH, Hang D, McGraw M, Avery EG, Markowitz AH, Park SJ) J Card Surg 2015 Jul;30(7):547-54 54 Citations |
| 2 | Up-regulation of microRNA-21 mediates isoflurane-induced protection of cardiomyocytes. (Olson JM, Yan Y, Bai X, Ge ZD, Liang M, Kriegel AJ, Twaroski DM, Bosnjak ZJ) Anesthesiology 2015 Apr;122(4):795-805 46 Citations |
| 2 | Thrombopoietin receptor agonists protect human cardiac myocytes from injury by activation of cell survival pathways. (Baker JE, Su J, Koprowski S, Dhanasekaran A, Aufderheide TP, Gross GJ) J Pharmacol Exp Ther 2015 Mar;352(3):429-37 11 Citations |
| 1 | The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial. (Drury NE, Howell NJ, Calvert MJ, Weber RJ, Senanayake EL, Lewis ME, Hyde JA, Green DH, Mascaro JG, Wilson IC, Graham TR, Rooney SJ, Viant MR, Freemantle N, Frenneaux MP, Pagano D, investigators) Eur J Cardiothorac Surg 2015 Mar;47(3):464-72 7 Citations |
| 2 | Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries. (Gaies MG, Jeffries HE, Niebler RA, Pasquali SK, Donohue JE, Yu S, Gall C, Rice TB, Thiagarajan RR) Pediatr Crit Care Med 2014 Jul;15(6):529-37 380 Citations |
| 1 | Zebrafish heart failure models for the evaluation of chemical probes and drugs. (Huang CC, Monte A, Cook JM, Kabir MS, Peterson KP) Assay Drug Dev Technol 2013;11(9-10):561-72 44 Citations |
| 1 | Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. (Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, Herschberger A, Hill KS, Moffet JR, Morrison RR, Norris AL, Petrovic A, Spear DA, Steiner ME, Talano JA, Tamburro RF, Wagner J, McArthur J, Pediatric Acute Lung Injury and Sepsis (PALISI) Network) Pediatr Crit Care Med 2013 Mar;14(3):261-7 62 Citations |
| 2 | Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. (Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, Su J, Baker JE, Linhardt RJ, Volkman BF) J Biol Chem 2013 Jan 04;288(1):737-46 78 Citations |
| 2 | Reduced mitochondrial Ca2+ loading and improved functional recovery after ischemia-reperfusion injury in old vs. young guinea pig hearts. (Rhodes SS, Camara AK, Heisner JS, Riess ML, Aldakkak M, Stowe DF) Am J Physiol Heart Circ Physiol 2012 Feb 01;302(3):H855-63 16 Citations |
| 1 | The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. (Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Laverdière C, Michon B, Schorin M, Schwartz CL, Cohen HJ, Lipshultz SE, Silverman LB, Sallan SE) Eur J Cancer 2011 Jun;47(9):1373-9 110 Citations |
| 1 | Delayed cardioprotection by inhaled anesthetics. (Pagel PS, Hudetz JA) J Cardiothorac Vasc Anesth 2011 Dec;25(6):1125-40 19 Citations |
| 1 | Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? (Rahman IA, Mascaro JG, Steeds RP, Frenneaux MP, Nightingale P, Gosling P, Townsend P, Townend JN, Green D, Bonser RS) Circulation 2010 Sep 14;122(11 Suppl):S53-9 233 Citations |
| 2 | Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. (Ge ZD, Pravdic D, Bienengraeber M, Pratt PF Jr, Auchampach JA, Gross GJ, Kersten JR, Warltier DC) Anesthesiology 2010 Jan;112(1):73-85 78 Citations |
| 1 | Cardioprotection by volatile anesthetics: established scientific principle or lingering clinical uncertainty? (Pagel PS) J Cardiothorac Vasc Anesth 2009 Oct;23(5):589-93 15 Citations |
| 2 | Modulation of mitochondrial bioenergetics in the isolated Guinea pig beating heart by potassium and lidocaine cardioplegia: implications for cardioprotection. (Aldakkak M, Stowe DF, Lesnefsky EJ, Heisner JS, Chen Q, Camara AK) J Cardiovasc Pharmacol 2009 Oct;54(4):298-309 28 Citations |
| 3 | Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12. (Veldkamp CT, Ziarek JJ, Su J, Basnet H, Lennertz R, Weiner JJ, Peterson FC, Baker JE, Volkman BF) Protein Sci 2009 Jul;18(7):1359-69 77 Citations |
| 1 | Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. (Konduri GG, Kim UO) Pediatr Clin North Am 2009 Jun;56(3):579-600, Table of Contents 132 Citations |
| 1 | Anaesthesia and myocardial ischaemia/reperfusion injury. (Frässdorf J, De Hert S, Schlack W) Br J Anaesth 2009 Jul;103(1):89-98 87 Citations |
| 1 | To explant or not to explant: an invasive and noninvasive monitoring protocol to determine the need of continued ventricular assist device support. (Osaki S, Sweitzer NK, Rahko PS, Murray MA, Hoffmann JA, Johnson MR, Edwards NM, Kohmoto T) Congest Heart Fail 2009;15(2):58-62 4 Citations |
| 2 | Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury. (Strande JL, Widlansky ME, Tsopanoglou NE, Su J, Wang J, Hsu A, Routhu KV, Baker JE) Cardiovasc Res 2009 Jul 15;83(2):325-34 21 Citations |
| 3 | Enhancement of nitric oxide release from nitrosyl hemoglobin and nitrosyl myoglobin by red/near infrared radiation: potential role in cardioprotection. (Lohr NL, Keszler A, Pratt P, Bienengraber M, Warltier DC, Hogg N) J Mol Cell Cardiol 2009 Aug;47(2):256-63 115 Citations |
| 1 | The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. (Venkateswaran RV, Steeds RP, Quinn DW, Nightingale P, Wilson IC, Mascaro JG, Thompson RD, Townend JN, Bonser RS) Eur Heart J 2009 Jul;30(14):1771-80 103 Citations |
| 2 | Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats. (Mio Y, Shim YH, Richards E, Bosnjak ZJ, Pagel PS, Bienengraeber M) Anesth Analg 2009 Mar;108(3):858-66 57 Citations |
| 3 | Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. (Chandran K, Aggarwal D, Migrino RQ, Joseph J, McAllister D, Konorev EA, Antholine WE, Zielonka J, Srinivasan S, Avadhani NG, Kalyanaraman B) Biophys J 2009 Feb 18;96(4):1388-98 165 Citations |
| 1 | Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection. (Romero-Perez D, Fricovsky E, Yamasaki KG, Griffin M, Barraza-Hidalgo M, Dillmann W, Villarreal F) J Am Coll Cardiol 2008 Sep 23;52(13):1086-94 65 Citations |
| 1 | Angiotensin-(1-7) as an antihypertensive, antifibrotic target. (Katovich MJ, Grobe JL, Raizada MK) Curr Hypertens Rep 2008 Jun;10(3):227-32 35 Citations |
| 1 | Physiological levels of glutamine prevent morphine-induced preconditioning in the isolated rat heart. (Heinen A, Huhn R, Hollmann MW, Preckel B, Zuurbier CJ, Schlack W, Frässdorf J, Weber NC) Eur J Pharmacol 2008 Oct 24;595(1-3):58-64 5 Citations |
| 2 | Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: the role of mitochondrial permeability transition. (Pagel PS, Krolikowski JG, Pratt PF Jr, Shim YH, Amour J, Warltier DC, Weihrauch D) Anesth Analg 2008 Sep;107(3):769-75 34 Citations |
| 2 | The mechanism of helium-induced preconditioning: a direct role for nitric oxide in rabbits. (Pagel PS, Krolikowski JG, Pratt PF Jr, Shim YH, Amour J, Warltier DC, Weihrauch D) Anesth Analg 2008 Sep;107(3):762-8 35 Citations |
| 1 | Additive cardioprotection by ethanol and sevoflurane: are sarcolemmal K ATP channels also involved? (Pagel PS) Anesth Analg 2008 Jun;106(6):1926; author reply 1926-7 2 Citations |
| 1 | A novel use of the implantable ventricular assist device for isolated right heart failure. (Osaki S, Edwards NM, Johnson MR, Kohmoto T) Interact Cardiovasc Thorac Surg 2008 Aug;7(4):651-3 8 Citations |
| 1 | Hyperpolarization-activated current (I(h)) contributes to excitability of primary sensory neurons in rats. (Hogan QH, Poroli M) Brain Res 2008 May 01;1207:102-10 41 Citations |
| 2 | Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection. (Jamnicki-Abegg M, Weihrauch D, Chiari PC, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR) J Cardiovasc Pharmacol 2007 Dec;50(6):670-6 16 Citations |
| 1 | Gadolinium limits myocardial infarction in the rat: dose-response, temporal relations and mechanisms. (Nicolosi AC, Strande JL, Hsu A, Fu X, Su J, Gross GJ, Baker JE) J Mol Cell Cardiol 2008 Feb;44(2):345-51 11 Citations |
| 1 | Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. (Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE) J Pharmacol Exp Ther 2008 Mar;324(3):1045-54 50 Citations |
| 3 | The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. (Wan TC, Ge ZD, Tampo A, Mio Y, Bienengraeber MW, Tracey WR, Gross GJ, Kwok WM, Auchampach JA) J Pharmacol Exp Ther 2008 Jan;324(1):234-43 74 Citations |
| 2 | Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. (Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, Hogg N) J Mol Cell Cardiol 2007 Oct;43(4):437-44 129 Citations |
| 2 | Role of S-nitrosothiol transport in the cardioprotective effects of S-nitrosocysteine in rat hearts. (Hogg N, Broniowska KA, Novalija J, Kettenhofen NJ, Novalija E) Free Radic Biol Med 2007 Oct 01;43(7):1086-94 34 Citations |
| 2 | Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. (Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt PF Jr) Anesth Analg 2007 Sep;105(3):562-9 114 Citations |
| 1 | Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms. (Baker JE, Kozik D, Hsu AK, Fu X, Tweddell JS, Gross GJ) J Cardiovasc Pharmacol 2007 Jun;49(6):337-45 43 Citations |
| 1 | SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. (Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE) Basic Res Cardiol 2007 Jul;102(4):350-8 94 Citations |
| 1 | Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application? (Pagel PS) Anesth Analg 2007 Apr;104(4):759-61 6 Citations |
| 1 | Early detection of digitalis-induced nonocclusive mesenteric ischemia using Doppler ultrasonography. (Awab A, Hamadani M, Saya S, Whitsett T) South Med J 2006 Oct;99(10):1142 2 Citations |
| 2 | Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. (Ge ZD, Peart JN, Kreckler LM, Wan TC, Jacobson MA, Gross GJ, Auchampach JA) J Pharmacol Exp Ther 2006 Dec;319(3):1200-10 89 Citations |
| 2 | Cardioprotection by volatile anesthetics: new applications for old drugs? (Pratt PF Jr, Wang C, Weihrauch D, Bienengraeber MW, Kersten JR, Pagel PS, Warltier DC) Curr Opin Anaesthesiol 2006 Aug;19(4):397-403 33 Citations |
| 1 | Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. (Marinovic J, Bosnjak ZJ, Stadnicka A) Anesthesiology 2006 Jul;105(1):98-104 47 Citations |
| 1 | A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts. (Zausig YA, Stowe DF, Zink W, Grube C, Martin E, Graf BM) Anesth Analg 2006 Jun;102(6):1646-52 17 Citations |
| 3 | Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature. (Dhanasekaran A, Al-Saghir R, Lopez B, Zhu D, Gutterman DD, Jacobs ER, Medhora M) Am J Physiol Heart Circ Physiol 2006 Aug;291(2):H517-31 61 Citations |
| 4 | Ischemia reperfusion dysfunction changes model-estimated kinetics of myofilament interaction due to inotropic drugs in isolated hearts. (Rhodes SS, Camara AK, Ropella KM, Audi SH, Riess ML, Pagel PS, Stowe DF) Biomed Eng Online 2006 Mar 02;5:16 4 Citations |
| 3 | Ischemia-reperfusion injury changes the dynamics of Ca2+-contraction coupling due to inotropic drugs in isolated hearts. (Rhodes SS, Ropella KM, Camara AK, Chen Q, Riess ML, Pagel PS, Stowe DF) J Appl Physiol (1985) 2006 Mar;100(3):940-50 11 Citations |
| 1 | Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection. (Nithipatikom K, Endsley MP, Moore JM, Isbell MA, Falck JR, Campbell WB, Gross GJ) Am J Physiol Heart Circ Physiol 2006 Feb;290(2):H500-5 42 Citations |
| 2 | Cardioprotection by volatile anesthetics. (Bienengraeber MW, Weihrauch D, Kersten JR, Pagel PS, Warltier DC) Vascul Pharmacol 2005;42(5-6):243-52 60 Citations |
| 2 | Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. (Rafiee P, Shi Y, Su J, Pritchard KA Jr, Tweddell JS, Baker JE) Basic Res Cardiol 2005 May;100(3):187-97 98 Citations |
| 2 | Negative inotropic drugs alter indexes of cytosolic [Ca(2+)]-left ventricular pressure relationships after ischemia. (Camara AK, Chen Q, Rhodes SS, Riess ML, Stowe DF) Am J Physiol Heart Circ Physiol 2004 Aug;287(2):H667-80 4 Citations |
| 3 | Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. (LaDisa JF Jr, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR) Am J Physiol Heart Circ Physiol 2004 Aug;287(2):H601-7 36 Citations |
| 2 | Cardiotonic drugs differentially alter cytosolic [Ca2+] to left ventricular relationships before and after ischemia in isolated guinea pig hearts. (Chen Q, Camara AK, Rhodes SS, Riess ML, Novalija E, Stowe DF) Cardiovasc Res 2003 Oct 01;59(4):912-25 14 Citations |
| 2 | A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. (Auchampach JA, Ge ZD, Wan TC, Moore J, Gross GJ) Am J Physiol Heart Circ Physiol 2003 Aug;285(2):H607-13 70 Citations |
| 1 | Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists. (Ge ZD, Auchampach JA, Piper GM, Gross GJ) J Cardiovasc Pharmacol 2003 Mar;41(3):481-8 10 Citations |
| 1 | Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of K(ATP) channel opening. (Patel HH, Ludwig LM, Fryer RM, Hsu AK, Warltier DC, Gross GJ) FASEB J 2002 Sep;16(11):1468-70 55 Citations |
| 1 | Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor. (Black RG Jr, Guo Y, Ge ZD, Murphree SS, Prabhu SD, Jones WK, Bolli R, Auchampach JA) Circ Res 2002 Jul 26;91(2):165-72 79 Citations |
| 4 | Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection. (Rafiee P, Shi Y, Kong X, Pritchard KA Jr, Tweddell JS, Litwin SB, Mussatto K, Jaquiss RD, Su J, Baker JE) Circulation 2002 Jul 09;106(2):239-45 83 Citations |
| 1 | Exercise, estrogen, and ischemic cardioprotection by heat shock protein 70. (Benjamin IJ, Christians E) Circ Res 2002 May 03;90(8):833-5 20 Citations |
| 1 | Protection of IB-MECA against myocardial stunning in conscious rabbits is not mediated by the A1 adenosine receptor. (Kodani E, Bolli R, Tang XL, Auchampach JA) Basic Res Cardiol 2001 Sep;96(5):487-96 20 Citations |
| 1 | Ouabain-induced coronary vasoconstriction in cats is not neurally mediated. (Nair BA, Murad YZ, Brody MJ, Gutterman DD) Clin Exp Pharmacol Physiol 2001 Jul;28(7):510-7 |
| 2 | Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. (Pratt PF, Li P, Hillard CJ, Kurian J, Campbell WB) Am J Physiol Heart Circ Physiol 2001 Mar;280(3):H1113-21 54 Citations |
| 1 | Perioperative considerations in a patient with orthostatic intolerance syndrome. (McHaourab A, Mazzeo AJ, May JA, Pagel PS) Anesthesiology 2000 Aug;93(2):571-3 6 Citations |
| 2 | Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. (Kersten JR, Montgomery MW, Pagel PS, Warltier DC) Anesth Analg 2000 Jan;90(1):5-11 247 Citations |
| 2 | Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. (Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC) J Cardiovasc Pharmacol 1999 Aug;34(2):219-28 147 Citations |
| 1 | A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. (Hibbard JU, Lindheimer M, Lang RM) Obstet Gynecol 1999 Aug;94(2):311-6 224 Citations |
| 1 | Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. (Poldermans D, Rambaldi R, Bax JJ, Cornel JH, Thomson IR, Valkema R, Boersma E, Fioretti PM, Breburda CS, Roelandt JR) Eur Heart J 1998 Nov;19(11):1712-8 45 Citations |
| 2 | Intracoronary levosimendan enhances contractile function of stunned myocardium. (Jamali IN, Kersten JR, Pagel PS, Hettrick DA, Warltier DC) Anesth Analg 1997 Jul;85(1):23-9 108 Citations |
| 2 | Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy. (Pagel PS, McGough MF, Hettrick DA, Lowe D, Tessmer JP, Jamali IN, Warltier DC) J Cardiovasc Pharmacol 1997 May;29(5):563-73 55 Citations |
| 2 | Increases in inotropic state without change in heart rate: combined use of dobutamine and zatebradine in conscious dogs. (Hettrick DA, Pagel PS, Lowe D, Tessmer JP, Warltier DC) Eur J Pharmacol 1996 Dec 05;316(2-3):237-44 9 Citations |
| 2 | Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency. (Pagel PS, Hettrick DA, Warltier DC) Basic Res Cardiol 1996;91(4):296-307 39 Citations |
| 2 | Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs. (Pagel PS, Harkin CP, Hettrick DA, Warltier DC) J Pharmacol Exp Ther 1995 Oct;275(1):127-35 18 Citations |
| 2 | Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. (Harkin CP, Pagel PS, Tessmer JP, Warltier DC) J Cardiovasc Pharmacol 1995 Aug;26(2):179-88 61 Citations |
| 2 | Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. (Pagel PS, Harkin CP, Hettrick DA, Warltier DC) Anesthesiology 1994 Oct;81(4):974-87 73 Citations |
| 2 | Direct negative inotropic and lusitropic effects of sevoflurane. (Harkin CP, Pagel PS, Kersten JR, Hettrick DA, Warltier DC) Anesthesiology 1994 Jul;81(1):156-67 94 Citations |
| 2 | Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs. (Pagel PS, Hettrick DA, Warltier DC) Anesthesiology 1993 Oct;79(4):753-65 21 Citations |
| 2 | Reversal of volatile anesthetic-induced depression of myocardial contractility by extracellular calcium also enhances left ventricular diastolic function. (Pagel PS, Kampine JP, Schmeling WT, Warltier DC) Anesthesiology 1993 Jan;78(1):141-54 44 Citations |
| 2 | Halothane reduces dysrhythmias and improves contractile function after global hypoperfusion in isolated hearts. (Buljubasic N, Marijic J, Stowe DF, Kampine JP, Bosnjak ZJ) Anesth Analg 1992 Mar;74(3):384-94 36 Citations |
| 2 | Amrinone reverses cardiac depression and augments coronary vasodilation with isoflurane in the isolated heart. (Rooney RT, Stowe DF, Marijic J, Bosnjak ZJ, Kampine JP) Anesthesiology 1991 Mar;74(3):559-67 5 Citations |
| 1 | Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154. (Al-Wathiqui MH, Shimshak TM, Brooks HL, Preuss KC, Wynsen JC, Gross GJ, Warltier DC) Pharmacology 1988;36(4):217-27 5 Citations |
| 1 | Cardiotonic effects of anthopleurin-A (AP-A), a polypeptide from a sea anemone, in dogs with a coronary artery stenosis. (Gross GJ, Warltier DC, Hardman HF, Shibata S) Eur J Pharmacol 1985 Apr 02;110(2):271-6 19 Citations |
© 2026 Clinical & Translational Science Institute